首页 产品中心 抗体 生化试剂 研究领域
服务与支持 定制服务 技术支持 促销活动 关于我们
登 录 注 册

Human Kappa Chain Rabbit mAb  (货号:AYM29086)

A
小A 扫码咨询
宿主: Rabbit克隆性: Monoclonal反应: HumanWBIHCIF/ICC
货号 AYM29086
靶点/基因 IGKC
宿主 Rabbit
克隆性 Monoclonal
反应种属 Human
应用 WB, IHC, IF/ICC

货号:AYM29086

规格价格
50ul ¥1150.00 加购物车
100ul ¥2100.00 加购物车
  • 产品信息

  • 应用指南

  • 相关产品

  • 抗原信息

  • 靶点信息

  • 资料与支持

  • 实验步骤

  • 常见问题

反应 Human
宿主 Rabbit
克隆性 Monoclonal
同种型 IgG
应用 WBIHCIF/ICC
推荐浓度 WB: 1:500 - 1:2000
IHC: 1:50 - 1:200
IF/ICC: 1:50 - 1:200
理论分子量 26kDa
实测分子量 26kDa
形式 Liquid
保存条件 Store at -20℃. Avoid freeze / thaw cycles.
Buffer: PBS with 0.75% BSA,50% glycerol,pH7.3.
偶联物 Unconjugated
阳性对照 Human serum,Mouse serum,Rat serum
细胞定位 blood microparticle,external side of plasma membrane,extracellular exosome,extracellular region,extracellular space,immunoglobulin complex, circulating,plasma membrane
纯化 Affinity purification

应用与推荐条件

快速判断怎么用

以下条件基于推荐浓度、验证图说明与通用实验要求整理,可作为预实验起点;不同样本和检测体系建议做梯度优化。

WB WB 推荐条件
推荐稀释 1:500 - 1:2000
建议样本/阳性对照 Human serum,Mouse serum,Rat serum
关键条件 建议使用新鲜裂解样本,按推荐稀释比例孵育一抗,并关注理论/实测分子量
预期结果 预期信号/条带约 26kDa
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IHC IHC 推荐条件
推荐稀释 1:50 - 1:200
建议样本/阳性对照 Human serum,Mouse serum,Rat serum
关键条件 石蜡切片建议优化抗原修复液 pH、修复时间和一抗孵育条件
预期结果 预期定位:blood microparticle,external side of plasma membrane,extracellular exosome,extracellular region,extracellular space,immunoglobulin complex, circulating,plasma membrane
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照
IF/ICC IF/ICC 推荐条件
推荐稀释 1:50 - 1:200
建议样本/阳性对照 Human serum,Mouse serum,Rat serum
关键条件 建议优化固定、通透和封闭条件,并设置二抗空白对照
预期结果 预期荧光定位:blood microparticle,external side of plasma membrane,extracellular exosome,extracellular region,extracellular space,immunoglobulin complex, circulating,plasma membrane
对照设置 建议设置阳性样本、阴性样本和二抗/同型对照

相关产品

查找相关产品 >>

抗原信息

抗原信息 Recombinant fusion protein corresponding to Human Human Kappa Chain.
序列
查看序列
RTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC

靶点信息

研究背景 Constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
基因 ID 3514
基因名 IGKC
Swiss P01834
别名 Human Kappa Chain,Human Kappa Chain Rabbit mAb,IGKC,Ig kappa chain C region,Ig kappa chain C region AG,Ig kappa chain C region CUM,Ig kappa chain C region EU,Ig kappa chain C region OU,Ig kappa chain C region ROY,Ig kappa chain C region TI
功能 Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).

资料与技术支持

验证数据

1 张验证图

页面顶部轮播可查看应用验证图,覆盖 WB / IHC / IF/ICC。

文献引用

暂无公开文献关联,欢迎联系技术支持获取更多应用案例。

咨询案例
客户评价

暂无客户评价,使用后可提交评价与实验图片。

提交反馈
技术支持

可协助确认应用、样本、稀释比例、阳性/阴性对照和实验条件。

进入支持中心
需要确认应用条件?

请提供货号 AYM29086、实验应用、样本类型和检测体系,技术支持可协助确认稀释比例、阳性/阴性对照和 COA/批次资料。

常见问题

当前页面标注应用包括 WB, IHC, IF/ICC,建议结合页面验证图和推荐稀释比例进行预实验优化。
可通过页面询价/留言入口提交货号和批号,技术支持会协助提供对应批次资料。
页面推荐条件可作为起始浓度,不同样本、固定方式和检测体系可能需要梯度优化。

实验步骤

实验步骤
AYM29086